Delivery Order SPE2DB20D3101-SPE2DB21FK0V3

Award Date 7/29/21
Potential Completion Date 7/30/21
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,477.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,556,314,540 units of the pharmaceutical product DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has a period of performance through February 22, 2022 and was awarded on a firm fixed-price basis. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
This federal contract award, valued at $2,524.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of September 19, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award, valued at $2,195.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, to support military and government healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of April 26, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,448.01 firm fixed-price delivery order is for the procurement of 4562351289 - DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has an ultimate completion date of October 2, 2023 and was awarded on September 29, 2023. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $9,596.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of February 6, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award for $16,655.60 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under the broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Cencora, Inc. holds with the DLA Troop Support Medical. The delivery order is for the pharmaceutical product DUROLANE 60 MG/3 ML SYRINGE 3ML. This contract supports the procurement of critical medical...
This federal contract award, valued at $2,208.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562339052 - DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The fixed-price delivery order, valued at $10,699.32, was awarded on March 4, 2022, with a completion date of March 7, 2022. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,948.19 firm fixed-price delivery order is for DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of February 8, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract award, valued at $2,769.78, is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK0V3
    Delivery Order

This federal contract award, valued at $3,262.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a final completion date of July 30, 2021. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was made without a set-aside designation, indicating full and open competition.

Generated 2/27/25, 9:51 AM